Budapest, Hungary

Genovéva Filipcsei

This inventor holds 14 USPTO granted patents and 14 published patent applications and 3 EPO patents. Top assignees: Druggability Technologies IP Holdco Limited, Nangenex Nanotechnology Incorporated, Druggability Technologies IP Holdco (Jersey) Ltd.. Active years: 2016-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Genovéva Filipcsei. Retrieved from https://idiyas.com/inventor/genovéva-filipcsei

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 

% Patents Active = 28.6

 

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2016-2020

Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Inventor Genovéva Filipcsei

Introduction

Genovéva Filipcsei is a prominent inventor based in Budapest, Hungary. With a remarkable portfolio of 14 patents, he has significantly contributed to the pharmaceutical field, particularly in the development of novel formulations aimed at enhancing patient care and treatment outcomes.

Latest Patents

His latest patents focus on innovative complexes that improve the solubility and efficacy of pharmaceuticals. One of his notable patents involves complexes of Celecoxib and its salts and derivatives. This invention emphasizes stable complexes with controlled particle size and improved dissolution rates, making it particularly beneficial for patients suffering from conditions such as osteoarthritis and cancer-related acute pain. The complexes provide rapid pain relief while minimizing gastrointestinal side effects, showcasing a medical advancement in acute pain management.

Another key patent entails complexes of Ivacaftor and its salts or derivatives. This formulation offers substantial advancements over existing treatments, featuring improved solubility and easy administration, which enhances dosing precision. The patents disclose comprehensive methods for preparing these complexes, pharmaceutical compositions, and potential uses in clinical settings, representing a significant stride in respiratory diseases treatment.

Career Highlights

Genovéva has collaborated with notable companies in the industry, including Druggability Technologies IP Holdco Limited and Nangenex Nanotechnology Incorporated. His work at these organizations underscores his commitment to advancing pharmaceutical innovations through cutting-edge research and development efforts.

Collaborations

Throughout his career, Genovéva Filipcsei has worked closely with esteemed colleagues, including Hristos Glavinas and Orsolya Basa-Dénes. Their combined expertise has fostered research that drives innovative solutions in drug formulations and therapeutic applications.

Conclusion

In conclusion, Genovéva Filipcsei's contributions to the field of pharmaceuticals through his patents and collaborations mark him as a leading figure in innovation. His work not only enhances drug efficacy but also improves patient care, reflecting a deep commitment to advancing medical science. As the landscape of pharmaceutical research continues to evolve, Filipcsei's inventions are set to play a pivotal role in shaping future treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…